Wealthcare Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,284
| Closed | -$227K | – | 72 |
|
|
2022
Q4 | $227K | Sell |
1,284
-19
| -1% | -$3.28K | 0.03% | 69 |
|
|
2022
Q3 | $213K | Sell |
1,303
-5
| -0.4% | -$846 | 0.03% | 63 |
|
|
2022
Q2 | $232K | Sell |
1,308
-259
| -17% | -$46.1K | 0.03% | 62 |
|
|
2022
Q1 | $278K | Buy |
+1,567
| New | +$267K | 0.03% | 68 |
|
|
2021
Q2 | – | Sell |
-940
| Closed | -$155K | – | 371 |
|
|
2021
Q1 | $155K | Buy |
+940
| New | +$152K | 0.02% | 82 |
|
|
2020
Q2 | – | Sell |
-989
| Closed | -$130K | – | 148 |
|
|
2020
Q1 | $130K | Sell |
989
-159
| -14% | -$22.6K | 0.02% | 61 |
|
|
2019
Q4 | $167K | Buy |
1,148
+179
| +18% | +$24.3K | 0.02% | 63 |
|
|
2019
Q3 | $125K | Hold |
969
| – | – | 0.02% | 70 |
|
|
2019
Q2 | $135K | Hold |
969
| – | – | 0.02% | 64 |
|
|
2019
Q1 | $135K | Hold |
969
| – | – | 0.02% | 65 |
|
|
2018
Q4 | $125K | Buy |
969
+648
| +202% | +$90.4K | 0.02% | 62 |
|
|
2018
Q3 | $44K | Hold |
321
| – | – | 0.01% | 96 |
|
|
2018
Q2 | $39K | Hold |
321
| – | – | ﹤0.01% | 98 |
|
|
2018
Q1 | $41K | Buy |
321
+40
| +14% | +$5.41K | ﹤0.01% | 92 |
|
|
2017
Q4 | $39K | Sell |
281
-99
| -26% | -$13.8K | ﹤0.01% | 97 |
|
|
2017
Q3 | $49K | Hold |
380
| – | – | 0.01% | 80 |
|
|
2017
Q2 | $50K | Buy |
380
+1
| +0.3% | +$128 | 0.01% | 80 |
|
|
2017
Q1 | $47K | Hold |
379
| – | – | 0.01% | 81 |
|
|
2016
Q4 | $44K | Buy |
379
+1
| +0.3% | +$116 | 0.01% | 80 |
|
|
2016
Q3 | $45K | Hold |
378
| – | – | 0.01% | 76 |
|
|
2016
Q2 | $46K | Hold |
378
| – | – | 0.01% | 74 |
|
|
2016
Q1 | $41K | Sell |
378
-50
| -12% | -$5.18K | ﹤0.01% | 85 |
|
|
2015
Q4 | $44K | Hold |
428
| – | – | 0.01% | 88 |
|
|
2015
Q3 | $40K | Sell |
428
-80
| -16% | -$7.74K | ﹤0.01% | 99 |
|
|
2015
Q2 | $50K | Sell |
508
-3,399
| -87% | -$340K | 0.01% | 102 |
|
|
2015
Q1 | $393K | Buy |
3,907
+3,549
| +991% | +$361K | 0.05% | 62 |
|
|
2014
Q4 | $37K | Buy |
358
+19
| +6% | +$2K | 0.01% | 93 |
|
|
2014
Q3 | $36K | Hold |
339
| – | – | 0.01% | 92 |
|
|
2014
Q2 | $35K | Buy |
339
+137
| +68% | +$13.8K | 0.01% | 88 |
|
|
2014
Q1 | $20K | Buy |
202
+122
| +153% | +$11.3K | ﹤0.01% | 106 |
|
|
2013
Q4 | $7K | Buy |
80
+51
| +176% | +$4.7K | ﹤0.01% | 89 |
|
|
2013
Q3 | $3K | Hold |
29
| – | – | ﹤0.01% | 100 |
|
|
2013
Q2 | $2K | Buy |
+29
| New | +$2.46K | ﹤0.01% | 111 |
|
Other funds holding JNJ
Wealthcare Capital Management's JNJ Position: Q1 2023 in Review
Wealthcare Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2023, closing a stake of 1,284 shares — an estimated $227K sold.
Wealthcare Capital Management first reported a position in JNJ in Q2 2013 and held it in 33 quarters. The position peaked at $393K in Q1 2015. 3,728 funds tracked by Wall St. Rank hold JNJ as of Q1 2023.
- Wealthcare Capital Management reported no remaining Johnson & Johnson position as of Q1 2023 after selling out during the quarter.
- Wealthcare Capital Management sold 1,284 Johnson & Johnson shares in Q1 2023, an estimated $227K.
- Wealthcare Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 33 quarters.
- Wealthcare Capital Management's Johnson & Johnson position peaked at $393K in Q1 2015.
- 3,728 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2023.
Based on Wealthcare Capital Management's 13F filing for Q1 2023, filed 4 May 2023.